Kaneka agrees to supply active pharmaceutical ingredients for Avigan®Tablet

16. April 2020

Kaneka agrees to supply active pharmaceutical ingredients for Avigan®Tablet

Kaneka Corporation has reached an agreement with FUJIFILM Corporation to supply drug substances for anti-influenza drug, Avigan®Tablet (general name: favipiravir), for the novel coronavirus disease.

While COVID-19 continues to spread, the Japanese government has decided to increase its stockpiles of Avigan®Tablet, which is expected to be effective against COVID-19, for up to 2 million people, and FUJIFILM Corporation has expanded its production system and started increasing its production of Avigan®Tablet.

Weitere Informationen finden Sie unter www.kaneka.co.jp/en/service/news/nr20200416/

Weitere Newsartikel ansehen

Aktuelles